Pain News and Research

Latest Pain News and Research

Forest Laboratories third quarter net sales increase 6.7% to $1,063.9 million

Forest Laboratories, Inc., an international pharmaceutical manufacturer and marketer, announced that reported earnings per share equaled $1.11 in the third quarter of fiscal 2011 after taking a charge for a new product licensing fee of $66.1 million or $0.23 per share, net of tax.

18 Jan 2011

Cadence launches OFIRMEV pain medication in the U.S.

Cadence Pharmaceuticals, Inc. today announced the launch of OFIRMEV™ (acetaminophen) injection, the first and only intravenous (IV) formulation of acetaminophen to be approved in the United States. The U.S. Food and Drug Administration (FDA) approved OFIRMEV in November 2010 for the management of mild to moderate pain, the management of moderate to severe pain with adjunctive opioid analgesics, and the reduction of fever.

18 Jan 2011

Rotator cuff surgery does not fully restore normal shoulder motion, strength: Study

Shoulder motion after rotator cuff surgery remains significantly different when compared to the patient's opposite shoulder, according to a Henry Ford Hospital study.

18 Jan 2011

PecFent accepted in Scotland for treatment of breakthrough cancer pain

Archimedes Pharma Ltd., a leading international specialty pharma company, today announced the decision by the Scottish Medicines Consortium to accept PecFent for use within NHS Scotland. PecFent is indicated for the treatment of breakthrough pain in adults who are already receiving maintenance opioid therapy for chronic cancer pain.

18 Jan 2011

McNeil Consumer Healthcare initiates voluntary recall

In consultation with the U.S. Food and Drug Administration, McNeil Consumer Healthcare, Division of McNEIL-PPC, Inc. is voluntarily recalling, at the wholesale level, certain lots of TYLENOL® 8 Hour, TYLENOL® Arthritis Pain, and TYLENOL® upper respiratory products, and certain lots of BENADRYL®, SUDAFED PE®, and SINUTAB® products distributed in the United States, the Caribbean, and Brazil.

18 Jan 2011

New study reveals measles viral gene plays key role in development of PD

A gene from the measles virus plays a key role in the development of Paget's disease of bone, according to a team of researchers led by the University of Pittsburgh School of Medicine.

18 Jan 2011

Diamyd commences NP2 Enkephalin Phase II trial to reduce cancer pain

Diamyd has dosed the first subject in a Phase II clinical trial in the United States evaluating the ability of the candidate drug NP2 Enkephalin to reduce cancer pain.

17 Jan 2011

Painkillers and heart attack risk

A new study has shown that taking certain commonly used painkillers for long periods or in high doses increases the risk of heart attacks or strokes. The study comes from researchers from Bern University and is published in the British Medical Journal.

16 Jan 2011

Roundup: Texas insurance exchange proposal; Ill. safety net hole; Iowa abortion decision

A key House GOP health policy writer has filed legislation to create a state-run health insurance exchange in Texas. A bill by Rep. John Zerwas, R-Katy, would create a Texas Health Insurance Connector, or simplified insurance market.

14 Jan 2011

Vitrolife receives patent protection for Swemed Sense needle in European markets

Swemed Sense™ is a unique needle that is used for the collection of oocytes in connection with IVF. The approved patent means that Vitrolife has both design protection and product patent protection for Swemed Sense™ in strategically important European markets. A patent has also been applied for in other prioritized markets.

14 Jan 2011

Covidien announces support for FDA on safe use of acetaminophen

Covidien, a leading global provider of healthcare products and the world's largest producer of acetaminophen, supports the U.S. Food and Drug Administration (FDA) on the safe use of acetaminophen.

14 Jan 2011

Orexo, Invida enter exclusive licensing and distribution agreement for Abstral in Asia Pacific

Orexo AB and Invida Group Private Limited today announced the signing of an exclusive licensing and distribution agreement, covering the Asia Pacific region for Abstral™, Orexo's product for the treatment of breakthrough cancer pain.

14 Jan 2011

FDA asks manufacturers to eliminate higher-dose prescription combination acetaminophen products

The U.S. Food and Drug Administration is asking manufacturers of prescription combination products that contain acetaminophen to limit the amount of acetaminophen to no more than 325 milligrams in each tablet or capsule.

14 Jan 2011

CJSM highlights emerging issues in sport medicine

Should electrocardiograms be included in cardiovascular screening of athletes? What's the current status of research into long-term effects of concussions? These and other hot topics are the focus of the January Clinical Journal of Sport Medicine, a special issue on "Emerging Issues in Sport Medicine."

14 Jan 2011

20% of cancer survivors experience chronic pain: Study

Surviving cancer may also mean surviving pain, according to a study by the University of Michigan Health System showing 20 percent of cancer survivors at least two years post diagnosis have current cancer-related chronic pain.

13 Jan 2011

FDA approves Cumberland's Acetadote Injection

Cumberland Pharmaceuticals today announced that it has received approval from the U.S. Food and Drug Administration for a new formulation of Acetadote Injection, the Company's product used to treat acetaminophen poisoning.

13 Jan 2011

FDA calls for cuts in Acetaminophen in painkillers

The US FDA has asked for a limit on the amount of acetaminophen in prescription pain medicines in an effort to reduce the risk of liver damage. The announcement yesterday asked manufacturers to limit combination drugs such as the opioids Percocet and Vicodin to 325 milligrams of acetaminophen per pill and asked them to carry a “black box” warning about potential liver failure. At present these combinations carry up to 750 milligrams of acetaminophen.

13 Jan 2011

Abuse of legal substances

The Internet, smart phones and teens' endless search for self-acceptance in their technology connected yet isolated world is driving a revival of substance abuse of salvia, an herb from flower seeds that induces psychedelic effects but is not detectable with usual drug tests, and synthetic cannabis, a psychoactive herbal and chemical concoction, also undetectable, popularly known around high schools as "spice".

13 Jan 2011

First international conference on pediatric psychological trauma in infants and young children

The First International Conference: Pediatric Psychological Trauma in Infants and Young Children from Illness, Injury and Medical Intervention now available on DVD in its entirety, brought together ten of the most respected, multidisciplinary pediatric researchers and clinicians to present their individual assessments on the status of the care of young children who continue to be victims of psychological trauma from illness, injury and medical intervention.

13 Jan 2011

Robot-assisted surgery improves outcomes in uterine, endometrial, and cervical cancer patients

Robot-assisted surgery dramatically improves outcomes in patients with uterine, endometrial, and cervical cancer, said researchers at the Jewish General Hospital's Lady Davis Institute for Medical Research in Montreal. Moreover, because of fewer post-operative complications and shorter hospital stays, robotic procedures also cost less.

13 Jan 2011

Pain News and Research

Latest Pain News and Research

Forest Laboratories third quarter net sales increase 6.7% to $1,063.9 million

Cadence launches OFIRMEV pain medication in the U.S.

Rotator cuff surgery does not fully restore normal shoulder motion, strength: Study

PecFent accepted in Scotland for treatment of breakthrough cancer pain

McNeil Consumer Healthcare initiates voluntary recall

New study reveals measles viral gene plays key role in development of PD

Diamyd commences NP2 Enkephalin Phase II trial to reduce cancer pain

Painkillers and heart attack risk

Roundup: Texas insurance exchange proposal; Ill. safety net hole; Iowa abortion decision

Vitrolife receives patent protection for Swemed Sense needle in European markets

Covidien announces support for FDA on safe use of acetaminophen

Orexo, Invida enter exclusive licensing and distribution agreement for Abstral in Asia Pacific

FDA asks manufacturers to eliminate higher-dose prescription combination acetaminophen products

CJSM highlights emerging issues in sport medicine

20% of cancer survivors experience chronic pain: Study

FDA approves Cumberland's Acetadote Injection

FDA calls for cuts in Acetaminophen in painkillers

Abuse of legal substances

First international conference on pediatric psychological trauma in infants and young children

Robot-assisted surgery improves outcomes in uterine, endometrial, and cervical cancer patients

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Pain News and Research

Latest Pain News and Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Newsletters you may be interested in